Ireland
--:--IST
Latest
Clinical Trials in Brazil / NCT07188350
Recruiting Not applicable

Neuromuscular Electrical Stimulation in a Patient on Invasive Mechanical Ventilation (MOVCARE)

NCT07188350 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-09-04
Last updated
2026-03-25

Condition(s) studied

Mechanical VentilationCritical IllnessIntensive Care Unit PatientsMuscle Weakness ConditionNeuromuscular Electrical Stimulation (NMES)

Investigational drug(s) / intervention(s)

Conventional Physical TherapyNeuromuscular Electrical Stimulation (NMES)

Conventional Physical Therapy: Individualized physical therapy including progressive mobility (e.g., bed exercises, sitting on the edge of the bed, standing, transfers, and ambulation) and respiratory therapy tailored to the patient's clinical condition. Delivered daily by trained professionals.

Neuromuscular Electrical Stimulation (NMES): NMES will be applied to both lower limbs once or twice daily for 20 consecutive days. Electrodes will be positioned on the vastus lateralis, vastus medialis, tibialis anterior, hamstrings, and gastrocnemius muscles. The stimulation protocol includes progressive parameters to induce visible and effective muscle contractions.

Study summary

This clinical study aims to compare the effects of conventional physical therapy alone versus conventional physical therapy combined with neuromuscular electrical stimulation (NMES) in patients admitted to the ICU and undergoing invasive mechanical ventilation. Participants will be randomly assigned to receive either conventional physical therapy or the same therapy plus NMES applied to the lower limbs. The protocol includes muscle-specific stimulation parameters and safety criteria to postpone sessions in cases of clinical instability. The primary goal is to assess whether NMES improves muscle function and recovery in critically ill patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients will be eligible if they are 18 years or older, are under invasive mechanical ventilation (IMV), and are expected to require IMV for more than 48 hours. Exclusion Criteria: * Body mass index (BMI) greater than or equal to 35 kg/m²; * Length of ICU stay longer than 7 ICU-free days or more than 3 continuous days of invasive mechanical ventilation (IMV) before enrollment; * Known intracranial process (e.g., stroke, intracranial hypertension); * Neuromuscular disease (e.g., Guillain-Barré syndrome, myasthenia gravis) at ICU admission; * Inability to speak Portuguese or pre-existing cognitive impairment prior to ICU admission; * Any condition that prevents neuromuscular electrical stimulation (NMES) treatment or assessment of the primary outcome in both legs (e.g., skin lesions, fractures, or amputation); * inability to transfer from bed to chair with or without assistance prior to hospital admission; * Cardiac arrest as the cause of ICU admission or cardiac arrest before screening; * Deep vein thrombosis (DVT) or pulmonary embolism (PE) treated for less than 48 hours; * Pregnant patients; * Known or suspected malignancy in the legs; * Any care limitation including a do-not-resuscitate order.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Moinhos de Vento Porto Alegre Rio Grande do Sul Recruiting

More Hospital Moinhos de Vento trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07188350 on ClinicalTrials.gov ↗ ← All trials in Brazil